Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab

BACKGROUND/AIM: Radiotherapy (RT) is an effective local treatment for hepatocellular carcinoma (HCC). However, whether additional RT is safe and effective in patients with advanced HCC receiving atezolizumab plus bevacizumab remains unclear. This retrospective cohort study aimed to evaluate the feas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae Hyun, Kim, Bo Hyun, Cho, Yu Ri, Koh, Young-Hwan, Park, Joong-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Liver Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565546/
https://www.ncbi.nlm.nih.gov/pubmed/37488926
http://dx.doi.org/10.17998/jlc.2023.04.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565546/
https://www.ncbi.nlm.nih.gov/pubmed/37488926
http://dx.doi.org/10.17998/jlc.2023.04.14

Ejemplares similares